---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-034689"
form_type: "8-K"
ticker: "GRDX"
cik: "0001604191"
company_name: "GridAI Technologies Corp."
filed_at: "2025-04-14T23:59:59+00:00"
generated_at: "2026-05-23T15:28:08.827972+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Entero Therapeutics receives Nasdaq deficiency notice for stockholders' equity shortfall

## Summary
- Stockholders' equity of ($3,876,738) as of Dec 31, 2024, well below Nasdaq's $2.5M minimum.
- Company also failed alternative compliance standards for market value or net income.
- Must submit compliance plan by May 26, 2025; Nasdaq may grant extension to Oct 8, 2025.
- Company intends to submit a plan, but no assurance of acceptance or regaining compliance.

## SEC filing metadata
- accession: 0001104659-25-034689
- form_type: 8-K
- ticker: GRDX
- cik: 0001604191
- company_name: GridAI Technologies Corp.
- filed_at: 2025-04-14T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.85
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1604191/000110465925034689/0001104659-25-034689-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1604191/000110465925034689/tm2512284d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-034689
- JSON: https://secwatch.observer/filing/0001104659-25-034689.json
- Plain text: https://secwatch.observer/filing/0001104659-25-034689.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.